These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 11172697)
1. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors. Skiles JW; Gonnella NC; Jeng AY Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697 [TBL] [Abstract][Full Text] [Related]
2. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors. Skiles JW; Gonnella NC; Jeng AY Curr Med Chem; 2004 Nov; 11(22):2911-77. PubMed ID: 15544483 [TBL] [Abstract][Full Text] [Related]
3. Progress in the development of matrix metalloproteinase inhibitors. Tu G; Xu W; Huang H; Li S Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Maskos K; Bode W Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538 [TBL] [Abstract][Full Text] [Related]
6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects. Levin M; Udi Y; Solomonov I; Sagi I Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874 [TBL] [Abstract][Full Text] [Related]
7. Structural studies of matrix metalloproteinases. Borkakoti N J Mol Med (Berl); 2000; 78(5):261-8. PubMed ID: 10954198 [TBL] [Abstract][Full Text] [Related]
8. Biology of metalloproteinases. Amălinei C; Căruntu ID; Bălan RA Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181 [TBL] [Abstract][Full Text] [Related]
9. The application of x-ray, NMR, and molecular modeling in the design of MMP inhibitors. Rush TS; Powers R Curr Top Med Chem; 2004; 4(12):1311-27. PubMed ID: 15320728 [TBL] [Abstract][Full Text] [Related]
10. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG Cells; 2020 May; 9(5):. PubMed ID: 32466129 [TBL] [Abstract][Full Text] [Related]
15. Quest for selectivity in inhibition of matrix metalloproteinases. Brown S; Meroueh SO; Fridman R; Mobashery S Curr Top Med Chem; 2004; 4(12):1227-38. PubMed ID: 15320723 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results. Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623 [TBL] [Abstract][Full Text] [Related]
17. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327 [TBL] [Abstract][Full Text] [Related]